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A B S T R A C T
Purpose: To describe 2-year and long-term outcomes (ﬁve or ten years) after resective epilepsy surgery
in children operated before the age of four years.
Methods: This prospective, population based, longitudinal study is based on data from the Swedish
National Epilepsy Surgery Register 1995–2010. The following variables were analysed: seizure
frequency, antiepileptic drug treatment (AED), neurological deﬁcits, type of operation, histopathological
diagnosis and perioperative complications.
Results: During the study period 47 children under four years had resective surgery. A majority had
seizure onset within the ﬁrst year of life, and the median age at surgery was two years and one month.
Two thirds had neurodevelopmental abnormalities. Temporal lobe resection, frontal lobe resection and
hemispherotomy predominated. A majority had malformations of cortical development. There was one
major perioperative complication. At the 2-year follow-up, 21/47 children (45%) were seizure free, eight
of whom were off medication. At the long-term follow-up, 16/32 (50%) were seizure-free and 11 of them
off medication. Another ten (31%) had 75% reduction in seizure frequency. Fourteen children (44%) had
sustained seizure freedom from surgery to the long-term follow-up.
Conclusion: This is the ﬁrst prospective, population based, longitudinal study to show that a favourable
seizure outcome is achievable in a majority of infants and young children undergoing resective epilepsy
surgery and that the improvements are consistent over time. Many can also stop taking AEDs. The
ﬁndings emphasise the importance of early referral to epilepsy surgery evaluation in cases of medically
intractable epilepsy in infants and young children.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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option of last resort associated with considerable risks of
perioperative morbidity, resective procedures in infants and young
children are now considered relatively safe due to advances in
neurosurgery, anaesthesia and paediatric intensive care. Further-
more, modern neuroimaging and neurophysiological techniques
permit better selection of suitable candidates for epilepsy surgery
[1–3].
The primary goal of epilepsy surgery is freedom from seizures, if
possible together with antiepileptic drug discontinuation. In
addition to the obvious beneﬁts of seizure relief, the case for
early intervention largely rests upon the assumption that these
often severely impaired children can achieve a better develop-
mental trajectory if they are spared the harmful effects ofserved.
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crucial stages of brain development [4–9]. Moreover, postsurgical
adverse neurological effects, typically verbal memory impairment
after mesial temporal lobe surgery, are considered less prominent
in younger patients due to brain plasticity [10].
There are consistent reports supporting that a favourable
seizure outcome is achievable in a majority of infants and young
children undergoing resective surgery; seizure freedom rates
range from 48% to 73% [9,11–17]. However, longitudinal data on
long-term results are scarce as previous studies are almost
exclusively retrospective and cross-sectional.
The aims of this study are to describe aetiology, surgical
procedures, perioperative complications and outcome in terms of
seizure frequency and antiepileptic drug use in a prospective,
population based, observational cohort of children under four
years of age undergoing resective epilepsy surgery in Sweden
between 1995 and 2010.
2. Methods
This study is an analysis of data from the Swedish National
Epilepsy Surgery Register. Pre-, peri- and postoperative data on all
patients undergoing epilepsy surgery have been reported to the
register since 1990 and data reporting has been entirely
prospective since 1995. Patients or, when applicable, their parents
have given informed consent prior to the start of data collection.
The 2-year follow-up is conducted at each epilepsy centre
whereas the 5- and 10-year follow-up data are collected in
structured telephone interviews. Five- and 10-year follow-ups
have been conducted since 2005. Thus, in children operated on
between 1995 and 1999, only 10-year follow-up data are
available. When both 5- and 10-year follow-ups have been
performed in one child (children operated on 2000–2003) only
data from the 10-year follow-up were analysed. The study was
approved by the Regional Board of Medical Ethics at the University
of Gothenburg.
For this study, data related to the following variables were
analysed: seizure frequency (mean number of monthly seizures
during the year preceding surgery), AED treatment, neurological
deﬁcits or other clinical ﬁndings, type of surgical procedure,
histopathological diagnosis and perioperative complications.
Seizure outcome was graded as follows: seizure-free (without
or with aura), 75% reduction, 50–74% reduction, 0–49%
reduction in seizure frequency and increased seizure frequency
after surgery. In case of persisting seizures, the change in mean
monthly frequency was calculated based on data from the year
before the follow-up.
In cases of reoperation, 2-year follow-up was conducted two
years after the second operation. AED use is described as median
number of AEDs used preoperatively and at follow-up. As to
aetiologies, the children with malformations of cortical develop-
ment were classiﬁed as having either FCD (type I, II or
unspeciﬁed), PMG or hemimegalencephaly. Further categorisa-
tion was not possible. One of the reasons for this is that
the classiﬁcations of FCD and hence the categorisations in the
register have changed over time. Perioperative complications
were graded as major (remaining sequelae >3 months after
surgery) or minor (no sequelae 3 months after surgery), as earlier
deﬁned [18]. Long-term outcomes include data from the 5- or 10-
year follow-ups.
2.1. Statistical methods
The results are described by means of frequencies and
percentages. The number of children included in the study was
considered too small to conduct any further analyses.3. Results
Forty-seven children (23 males, 24 females) underwent a total
of 55 operations in Sweden during the study period. Notably, in one
region with 1.6 million inhabitants (out of 9.5 million) only one
child under the age of four was operated. All 47 were followed up
two years postoperatively. Thirty-two children completed long-
term follow-up (Fig. 1).
Preoperative characteristics are presented in Table 1. Onset of
epilepsy was during the ﬁrst year of life in the majority. The
median age at ﬁrst operation was 2 years 1 month (range 2
months–4 years). The median duration of epilepsy was 1 year 3
months (range 1 month–3 years 11 months) and did not differ
signiﬁcantly between the periods 1995–1999, 2000–2004 and
2005–2010. The median preoperative seizure frequency was
150/month (range 3–3000) and most children were treated with
more than one AED. In addition, several AEDs had previously
been tried without success. Neurodevelopmental impairments
were common, including motor deﬁcits and intellectual disabili-
ty. Fifteen (32%) had no neuroimpairment at the preoperative
assessment.
Surgical procedures and aetiologies as determined by the
results of the histopathological examinations are shown in
Table 2. One type of operation is listed per child; in cases of
reoperation, the second procedure is listed. The most common
surgical procedures were temporal lobe resection (TLR) (n = 12),
frontal lobe resection (FLR) (n = 12) and hemispherotomy
(n = 12). Out of the eight reoperated children, four had comple-
tion of the initial hemispherotomy, one initially a multilobe
resection (MLR) followed by hemispherotomy. Two children
underwent extended FLR and one extended parietal lobe
resection (PLR). In addition, one child underwent FLR as a
reoperation after a ﬁrst operation prior to the study period. The
aetiology was classiﬁed as MCD in 29/47 children, making it
the predominant aetiology. Unspeciﬁed FCD (11 children) was
the most prevalent histopathological diagnosis in the MCD group
and in the whole study group.
Two perioperative complications, one major (epidural ab-
scess) and one minor (pneumonia) were registered. In addition,
two children received a ventriculoperitoneal shunt, one within
two years after a hemispherotomy and the other seven months
after a MLR.
3.1. Two-year follow-up: seizure outcome and AED use (n = 47)
Twenty-one children (45%) were seizure-free and 12 children
(26%) had 75% reduction in seizure frequency. Eight children
(17%) had 50–74% reduction and two children (4%) 0–49%
reduction in seizure frequency. Four children (9%) had an increased
seizure frequency. In all, 33 children (70%) had a favourable
outcome (seizure-free or 75% reduction of seizure frequency) at
the 2-year follow-up.
Twenty-ﬁve children (53%) used a lower number of AEDs at
the 2-year follow-up than preoperatively. Eight of those (17%)
were completely off AEDs and they were all seizure-free.
Although the median number of AEDs was unchanged at
follow-up, the median change in number of AEDs used was 1
(range 3 to +4). One child had received a vagus nerve stimulator
(VNS) within two years after surgery and one child was treated
with ketogenic diet.
3.2. Two-year follow-up: seizure outcome and type of surgical
procedures
Seizure outcome in relation to type of surgical procedure is
shown in Fig. 2. The TLR group had the best seizure outcome
Fig. 1. Flow chart of operations and follow-ups in 47 children operated 1995–2010. *one emigrated, two were reoperated >2 years after ﬁrst operation, one missing data (lost
to 10-year follow-up), one died of reasons unrelated to epilepsy (lost to 5-year follow-up).
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(7/12 seizure-free). The corresponding numbers in the FLR
group were 4/12 and in the MLR group 1/8. Two children
underwent PLR; both had 75% reduction in seizure frequency.
The one child undergoing occipital lobe resection (OLR) was
seizure-free.Table 1
Preoperative characteristics (n = 47).
Median Mean Range
Age at epilepsy onset 3 m 7 m 0 m–3 y 4 m
Age at ﬁrst operation 2 y 1 m 2 y 1 m 2 m–4 y
Epilepsy duration 1 y 3 m 1 y 6 m 1 m–3 y 11 m
Seizure frequency (per month) 150 298 3–3000
Number of AEDs used 2 2,2 0–4
Number of AEDs previously tried 1 1,8 0–9
n (%)
Motor impairment 17 (36)
Speech impairment 5 (11)
IQ 50–69 10 (21)
IQ <50 4 (9)
Developmental delay 4 (9)




Abbreviations: n: number; m: month; y: year; AED: antiepileptic drug.3.3. Two-year follow-up: seizure outcome and aetiology
Seizure outcome in relation to aetiology is shown in Fig. 3. The
children with low-grade tumours (n = 4) were all seizure-free at
the 2-year follow-up. None of the children with tuberous sclerosis
complex (n = 4) were seizure free. In the MCD group (n = 29), 13
children were seizure-free. The children with unspeciﬁed FCD had
the best outcome among the MCD subgroups. Three children in the
gliosis/other non-speciﬁc pathology group (n = 7) were seizure-
free, as was the one child with a vascular malformation. The child
with a cystic malformation had a 0–49% reduction in seizure
frequency, whereas the child without a histopathological diagnosis
had an increased seizure frequency.
3.4. Long-term follow up: longitudinal seizure outcome and AED use
(n = 32)
Fig. 4 shows the seizure outcome at the long-term follow-up.
Sixteen out of thirty-two children were seizure-free, 14 of
whom had been so since surgery (44%). Over the years between
2-year- and long-term follow-up, there were four cases of late
seizure recurrence and two cases of late remission. Of the four
children showing late seizure recurrence, two had only rare focal
seizures with impairment of consciousness (75% reduction
compared to preoperatively), one had focal seizures with secondary
Table 2
Aetiologies and types of surgical procedures (n = 47).
TLR n (%) FLR n (%) PLR n (%) OLR n (%) MLR n (%) Hemispherotomy n (%) Total n (%)
MCD 29 (61.7)
Hemimegalencephaly 1 7 8 (17.0)
PMG 1 2 3 (6.4)
FCD I 1 1 (2.1)
FCD II 2 2 1 1 6 (12.8)
FCD uspeciﬁed 3 5 2 1 11 (23.4)
Gliosis/non-speciﬁc 2 2 2 1 7 (14.9)
Low-grade tumour 4 4 (8.5)
TSC 1 2 1 4 (8.5)
Vascular malformation 1 1 (2.1)
Cystic malformation 1 1 (2.1)
No pathology report 1 1 (2.1)
Total n (%) 12 (25.5) 12 (25.5) 2 (4.3) 1 (2.1) 8 (17.0) 12 (25.5)
Abbreviations: n: number; TLR: temporal lobe resection; FLR: frontal lobe resection; PLR: parietal lobe resection; OLR: occipital lobe resection; MLR: multiple lobe resection;
MCD: malformation of cortical development; PMG: polymicrogyria; FCD: focal cortical dysplasia; TSC: tuberous sclerosis complex.
Fig. 2. Seizure outcome at 2-year follow-up related to type of surgical procedure (n = 47) n: number.
Fig. 3. Seizure outcome at 2-year follow-up related to aetiology (n = 47). n: number; PMG: polymicrogyria; FCD: focal cortical dysplasia; TSC: tuberous sclerosis complex.
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frequency compared to preoperatively (focal seizures without
impairment of consciousness). A favourable outcome was observed
in altogether 26 children (81%) at the long-term follow-up.The median number of AEDs used at the long-term follow-up
was 1 (range 0–4). Eleven children (34% of all, 69% of the 16
seizure-free), all of whom were seizure-free, had stopped AED
treatment. The child on ketogenic diet had a VNS implanted
Fig. 4. Flow chart of long-term seizure outcome in 32 children.
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VNS implanted within two years had a 75% reduction in seizure
frequency.
4. Discussion
This is the ﬁrst prospective, population based, longitudinal
study to show that resective epilepsy surgery yields persistent
seizure freedom or worthwhile reduction of seizure frequency in a
majority of cases when performed in infants and young children
with severe medically intractable epilepsy. This is in agreement
with previous retrospective cross-sectional studies on seizure
outcomes in the age group in which rates of seizure freedom
ranging from 48% to 73% have been reported [10–17]. With the
exception of the study by Steinbok et al., all studies to date in
the age group are small, making it hard to draw any deﬁnitive
conclusions about differences in seizure outcome [15]. Aetiolo-
gies, localisation of resection and preoperative MRI ﬁndings have
been shown to predict seizure outcome and the distribution of
these variables within a study group therefore inﬂuences the
results. Consequently, inclusion criteria related to these variables
must be taken into account when assessing outcomes. For
example, the study by Bittar et al. (73% seizure-free, n = 11) only
included children with an identiﬁable lesion on MRI as well as a
normal contralateral hemisphere [14]. In contrast, this study is
population based and thus includes all children operated during
the study period. Moreover, the differences in study design should
be taken into account as cross-sectional data on seizure outcomes,
collected during a rather wide time span, are not directly
comparable to either the 2-year- or the long-term outcomes in
this study.
When it comes to comparisons of seizure outcome after speciﬁc
resection types and aetiologies, the numbers are small in ourseries, as is the case in most previous studies on epilepsy surgery in
the very young. Maton et al. reported seizure outcomes after TLR
in 20 children below 5 years of age. At follow-up at least two years
after surgery, 65% were seizure free, a ﬁnding in line with our
results (67% seizure free at the 2-year follow-up) [19]. Hemi-
spherotomy is one of the most frequent types of surgery in studies
on infants and young children; rates of seizure freedom ranging
from 57% to 73% have been reported [9,13,15]. In our series, 58% of
the children were seizure-free two years after hemispherotomy. In
line with most surgical series in the age group, MCD was the
predominant aetiology in this study and 13 out of 29 children (45%)
were seizure-free at long-term follow-up. In a retrospective, cross-
sectional study by Otsuki et al. on 56 children with different forms
of MCD, 66% were seizure-free at last follow-up. The follow-up
period ranged from 1 to 11 years and 55% had been seizure-free
since surgery [20].
The proportion of seizure-free children in this series was
largely preserved between 2-year- and long-term follow-ups. This
ﬁnding is important as it implies that the risk of late seizure
recurrence is not higher in infants and young children compared
to older children and adults. Edelvik et al. reported a decrease in
rate of seizure freedom from 55% to 50% and 50% to 41% in children
0–18 years and adults, respectively, between 2-year and long-
term follow-ups [21]. In a recent study by Moosa et al. on seizure
outcome after hemispherotomy in children 0–18 years, the
seizure freedom rate decreased from 70% at two years to 60%
ﬁve years postoperatively which is in accordance with the present
study [22].
In this series, there was one major complication and no
deaths. Results from early studies suggested a considerable risk
of peri- or intraoperative mortality (1/12 and 2/32 children died
respectively) [11,12]. However, more recent studies, have not
reported any intra- or perioperative mortality with the exception
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[14–17].
A considerable proportion of the seizure-free children in this
series could discontinue antiepileptic medication (69% at long-
term follow-up). Previous studies of epilepsy surgery in this age
group have reported 25–50% of children to be off medication at
follow-up [11,13–16]. The development of children with
symptomatic epilepsy starting in the neonatal period or during
infancy often tends to take a detrimental course. In part this is
due to the underlying brain pathology, but the effects of AED
treatment and ongoing seizure activity are also considered to
have an inﬂuence [23,24]. The relative impacts of these factors
vary depending on the condition and even though there is not yet
any decisive data on the long-term effects of AED treatment on
the developing brain, freedom from both seizures and medication
is desirable. It is of interest to note that the proportion of seizure-
free children entirely off medication increased from 17% to 34%
between the 2-year- and the long-term follow-ups. It remains to
determine if attempts of withdrawal from antiepileptic medica-
tion should be done earlier in the postoperative period. A recently
published retrospective multi-centre study including 766 chil-
dren concluded that early attempted postoperative AED with-
drawal in seizure-free children did not affect seizure outcome at
the end of the study period. Thus, many children could possibly
be spared unnecessary and potentially harmful AED treatment, if
earlier withdrawal attempts were introduced into standard
clinical practice [25].
No signiﬁcant change in time from epilepsy onset to surgery
over the study period was observed in this study which is
unfortunate as a short duration of epilepsy has been shown to
predict an improved developmental trajectory [4–9]. This further
emphasises the importance of early referral of children with early
onset intractable epilepsy of suspected symptomatic aetiology for
epilepsy surgery evaluation [26]. Moreover, our ﬁnding of an
uneven distribution of operated patients over the country indicates
the possibility of a surgical treatment gap.
In keeping with previous studies, the neurological co-
morbidity in this series was high. Neurodevelopmental deﬁcits
were observed in a majority, including 14 children with
intellectual disability of varying degree. This number is to be
considered a minimum, since the developmental assessments
in infants with a catastrophic seizure situation may be difﬁcult.
Even though seizure freedom is the most comprehensively
investigated outcome measure in studies on paediatric epilepsy
surgery, other postoperative variables are equally important and
thus warrant further evaluation. As mentioned above, a bearing
hypothesis in early resective surgery is that the disruption of
uncontrolled seizure activity improves the postoperative neu-
rodevelopmental trajectory. There is some evidence supporting
this view but the studies suffer from methodological drawbacks
(small cohorts, heterogeneous aetiologies, retrospective, cross-
sectional design, different methods of assessing neurodevelop-
ment across studies) [4–9]. Consequently, further studies,
preferably multi-centre, prospective and longitudinal, as pointed
out by Beghi and Tonini, are needed to assess neurodevelop-
mental, behavioural and quality of life outcomes after epilepsy
surgery in infants and young children [27].
The major strength of this study is that, in contrast to most
studies, it is prospective and population based, including all
children operated in Sweden within the study period. The
longitudinal design with multiple structured follow-ups makes
it possible to give a more detailed account of the postoperative
period, including late remissions, seizure recurrences and changes
in AED use. The small size of the study cohort and its different
subgroups is a weakness, as is the lack of yearly monitoring of the
seizure situation.5. Conclusion
This study shows that a favourable seizure outcome is achievable
in a majority of infants and young children undergoing resective
epilepsy surgery, with few complications. The results are consistent
over time and a majority of the seizure-free children had also
discontinued antiepileptic medication at the long-term follow-up.
Finally, the ﬁndings of this study emphasise the importance and
gains of early referral to epilepsy surgery evaluation in cases of
medically intractable epilepsy in infants and young children.
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